Search Results - "Finn, Kathleen T"

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients by Cibeira, Maria Teresa, Sanchorawala, Vaishali, Seldin, David C., Quillen, Karen, Berk, John L., Dember, Laura M., Segal, Adam, Ruberg, Frederick, Meier-Ewert, Hans, Andrea, Nancy T., Sloan, J. Mark, Finn, Kathleen T., Doros, Gheorghe, Blade, Joan, Skinner, Martha

“…Previous studies have suggested that, in patients with AL amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation (HDM/SCT), the…”
Get full text

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial by Sanchorawala, Vaishali, Wright, Daniel G., Rosenzweig, Michael, Finn, Kathleen T., Fennessey, Salli, Zeldis, Jerome B., Skinner, Martha, Seldin, David C.

“…In immunoglobulin light chain (AL) amyloidosis, amyloid fibril deposits derived from immunoglobulin light chains produced by a clonal plasma cell dyscrasia…”
Get full text

Kidney dysfunction during lenalidomide treatment for AL amyloidosis by SPECTER, Richard, SANCHORAWALA, Vaishali, SELDIN, David C, SHELTON, Anthony, FENNESSEY, Salli, F'INN, Kathleen T, ZELDIS, Jerome B, DEMBERI, Laura M

“…Lenalidomide is an immunomodulatory agent used to treat plasma cell dyscrasias. We previously observed worsening of kidney function in a high proportion of…”
Get full text

Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease by Girnius, Saulius, Seldin, David C, Skinner, Martha, Finn, Kathleen T, Quillen, Karen, Doros, Gheorghe, Sanchorawala, Vaishali

“…1 Department of Medicine 2 Stem Cell Transplantation Program of the Section of Hematology-Oncology and 3 Amyloid Treatment and Research Program, Department of…”
Get full text

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation by Sanchorawala, Vaishali, Skinner, Martha, Quillen, Karen, Finn, Kathleen T., Doros, Gheorghe, Seldin, David C.

“…Long-term survival and outcome were determined for 80 patients with immunoglobulin light chain (AL) amyloidosis treated with high-dose melphalan and stem cell…”
Get full text

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis by Tapan, Umit, Seldin, David C., Finn, Kathleen T., Fennessey, Salli, Shelton, Anthony, Zeldis, Jerome B., Sanchorawala, Vaishali

Get full text

Experience implementing distress screening using the National Comprehensive Cancer Network distress thermometer at an urban safety-net hospital by Lo, Stephen B., Ianniello, Leanne, Sharma, Malti, Sarnacki, Diane, Finn, Kathleen T.

Get full text

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study by SKINNER, Martha, SANCHORAWALA, Vaishali, WIESMAN, Janice, QUILLEN, Karen, SWAN, Niall, WRIGHT, Daniel G, SELDIN, David C, DEMBER, Laura M, FALK, Rodney H, BERK, John L, ANDERSON, Jennifer J, O'HARA, Carl, FINN, Kathleen T, LIBBEY, Caryn A

“…AL amyloidosis is a fatal disease resulting from tissue deposition of amyloid fibrils derived from monoclonal immunoglobulin light chains. Treatment with oral…”
Get full text

Low‐dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis by Sanchorawala, Vaishali, Wright, Daniel G., Seldin, David C., Falk, Rodney H., Berk, John L., Dember, Laura M., Finn, Kathleen T., Skinner, Martha

“…Median survival of patients with AL amyloidosis with clinically significant cardiac involvement is 5 months when treated with cyclic melphalan and prednisone…”
Get full text

Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis by Sanchorawala, Vaishali, Finn, Kathleen T., Fennessey, Salli, Shelton, Anthony, Doros, Gheorghe, Zeldis, Jerome B., Seldin, David C.

Get full text

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center by Tsai, Stephanie B., Seldin, David C., Quillen, Karen, Berk, John L., Ruberg, Frederick L., Meier-Ewert, Hans, Sloan, J. Mark, Doros, Gheorghe, Finn, Kathleen T., Skinner, Martha, Sanchorawala, Vaishali

Get full text

Health Behaviors, Readiness to Change, and Interest in Health Promotion Programs Among Smokers With Lung Cancer and Their Family Members: A Pilot Study by Cooley, Mary E, Finn, Kathleen T, Wang, Qian, Roper, Kristin, Morones, Sandra, Shi, Ling, Litrownik, Dan, Marcoux, J Paul, Zaner, Ken, Hayman, Laura L

“…BACKGROUND:The diagnosis of lung cancer presents an opportunity to motivate individuals to adopt health-promoting behavior. Little attention has been given to…”
Get full text

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation by Seldin, David C., Anderson, Jennifer J., Sanchorawala, Vaishali, Malek, Karim, Wright, Daniel G., Quillen, Karen, Finn, Kathleen T., Berk, John L., Dember, Laura M., Falk, Rodney H., Skinner, Martha

“…Treatment of AL amyloidosis patients with high-dose melphalan chemotherapy followed by autologous peripheral blood stem cell transplantation (HDM/SCT) can…”
Get full text

Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis by Girnius, Saulius, Seldin, David C, Skinner, Martha, Finn, Kathleen T, Quillen, Karen, Doros, Gheorghe, Sanchorawala, Vaishali

“…High-dose melphalan chemotherapy and autologous peripheral blood stem cell transplantation (HDM/SCT) has been shown to result in a durable hematologic response…”
Get full text

REDUCTION IN VENTRICULAR WALL THICKNESS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND STEM-CELL TRANSPLANTATION FOR AL CARDIAC AMYLOIDOSIS by Ruberg, Frederick L, Sanchorawala, Vaishali, Berk, John, Finn, Kathleen T, Skinner, Martha, Seldin, David C, Meier-Ewert, Hans

Get full text

Amyloid Deposits in the Bone Marrow of Patients with Immunoglobulin Light Chain Amyloidosis Do Not Impact Stem Cell Mobilization or Engraftment by Cowan, Andrew J, Seldin, David C, Skinner, Martha, Quillen, Karen, Doros, Gheorghe, Tan, Josenia, O’Hara, Carl, Finn, Kathleen T, Sanchorawala, Vaishali

“…Amyloid deposits are often found in the bone marrow in patients with Immunoglobulin light chain (AL) amyloidosis. We sought to determine whether this affects…”
Get full text

Long-Term Outcome of Patients with AL Amyloidosis Treated with High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience at a Single Center by Sanchorawala, Vaishali, MD, Doros, Gheorghe, PhD, Quillen, Karen, MD, Sloan, J. Mark, MD, Shelton, Anthony C., RN, Brauneis, Dina, NP, Finn, Kathleen T., NP, Seldin, David C., MD, PhD

Get full text

A Multidisciplinary Team Approach for Diagnosis and Treatment of Patients with AL Amyloidosis by Finn, Kathleen T., NP, Fennessey, Salli, Shelton, Anthony C., RN, Brauneis, Dina, NP, Teschner, Taylor, Quillen, Karen, MD, Sloan, J. Mark, MD, Renteria, Anne S., MD, Seldin, David C., MD, PhD, Sanchorawala, Vaishali, MD

Get full text

Long-Term Outcome Of Patients With AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience At a Single Center by Sanchorawala, Vaishali, Doros, Gheorghe, Quillen, Karen, Sloan, John Mark, Shelton, Anthony C, Brauneis, Dina, Finn, Kathleen T, Seldin, David C

“…Aggressive treatment of AL amyloidosis with high dose intravenous melphalan followed by autologous stem cell transplant (HDM/SCT) is effective in inducing…”
Get full text

Melphalan, Lenalidomide and Dexamethasone Combination Therapy In Patients with AL Amyloidosis by Patel, Jaymin, Sloan, John Mark, Shelton, Anthony C, Finn, Kathleen T, Sanchorawala, Vaishali

“…Abstract 2924 Melphalan and dexamethasone treatment offers hematologic response, organ response and improved survival in subjects with AL Amyloidosis. In view…”
Get full text